World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
30078
World Ranking
14028
National Ranking
533

Guido Finazzi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Guido Finazzi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 334 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Guido Finazzi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Guido Finazzi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Guido Finazzi is affiliated with the Mario Negri Institute for Pharmacological Research in Italy. Their research spans multiple fields of study, predominantly focused on Medicine and Biochemistry, Genetics and Molecular Biology. Within these broader categories, their work delves into subfields such as Biotechnology, Infectious Diseases, Genetics, Food Science, and Hematology.

The scientist has contributed extensively to specific research topics including:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Listeria monocytogenes in Food Safety
  • Microbial Inactivation Methods
  • Botulinum Toxin and Related Neurological Disorders
  • Viral gastroenteritis research and epidemiology
  • Milk Quality and Mastitis in Dairy Cows
  • Acute Myeloid Leukemia Research

Frequent publication venues for Guido Finazzi's work include:

  • European Journal of Public Health
  • American Journal of Hematology
  • Leukemia
  • International Journal of Molecular Sciences
  • Toxins

Among notable recent papers, the following publications stand out:

  • Investigation and Follow-Up of a Staphylococcal Food Poisoning Outbreak Linked to the Consumption of Traditional Hand-Crafted Alm Cheese, 2020, Pathogens
  • How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey, 2020, Leukemia
  • COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey, 2020, Leukemia
  • Evaluation of the Virulence Potential of Listeria monocytogenes through the Characterization of the Truncated Forms of Internalin A, 2023, International Journal of Molecular Sciences
  • Infant Botulism: Checklist for Timely Clinical Diagnosis and New Possible Risk Factors Originated from a Case Report and Literature Review, 2021, Toxins

Guido Finazzi's research collaborations include frequent co-authors such as:

  • Virginia Filipello
  • Marina Nadia Losio
  • Sara Arnaboldi
  • G Magagna
  • Barbara Bertasi

The body of work by Guido Finazzi reflects engagement with complex biomedical and public health challenges, bridging molecular biology and clinical hematology with food safety and infectious disease topics.

Best Publications

  • Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of Thrombosis

    Sergio Cortelazzo;Guido Finazzi;Marco Ruggeri;Oscar Vestri

  • Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

    Tiziano Barbui;Giovanni Barosi;Gunnar Birgegard;Francisco Cervantes

  • Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

    Roberto Marchioli;Guido Finazzi;Giorgina Specchia;Rossella Cacciola

  • Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

    Ayalew Tefferi;Juergen Thiele;Attilio Orazi;Hans Michael Kvasnicka

  • Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia Vera

    Roberto Marchioli;Guido Finazzi;Raffaele Landolfi;Jack Kutti

  • Survival and prognosis among 1545 patients with contemporary polycythemia vera: An international study

    A Tefferi;E Rumi;G Finazzi;H Gisslinger

  • Long-term survival and blast transformation in molecularly-annotated essential thrombocythemia, polycythemia vera and myelofibrosis

    Ayalew Tefferi;Paola Guglielmelli;Dirk R. Larson;Christy Finke

  • The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto

    Paolo Rebulla;Guido Finazzi;Francesca Marangoni;Giuseppe Avvisati

  • A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).

    G. Finazzi;R. Marchioli;V. Brancaccio;P. Schinco

  • Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)

    Tiziano Barbui;Guido Finazzi;Alessandra Carobbio;Juergen Thiele

  • Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.

    Alessandro M. Vannucchi;Elisabetta Antonioli;Paola Guglielmelli;Alessandro Rambaldi

  • Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia.

    Sergio Cortelazzo;Piera Viero;Guido Finazzi;Anna D'Emilio

  • Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registry

    Guido Finazzi;Vincenzo Brancaccio;Marco Moia;Nicola Ciavarella

  • Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study.

    Guido Finazzi;Vanesa Caruso;Roberto Marchioli;Giovanni Capnist

  • Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera.

    Raffaele Landolfi;Leonardo Di Gennaro;Tiziano Barbui;Valerio De Stefano

  • Philadelphia chromosome-negative classical myeloproliferative neoplasms: Revised management recommendations from European LeukemiaNet

    Tiziano Barbui;Ayalew Tefferi;Alessandro M. Vannucchi;Francesco Passamonti

  • Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.

    Alessandra Carobbio;Juergen Thiele;Francesco Passamonti;Elisa Rumi

  • Myeloproliferative neoplasms and thrombosis

    Tiziano Barbui;Guido Finazzi;Anna Falanga

  • Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status

    Alessandra Carobbio;Guido Finazzi;Vittoria Guerini;Orietta Spinelli

  • Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera. Commentary

    Ayalew Tefferi;Raffaele Landolfi;Leonardo Di Gennaro;Tiziano Barbui

Frequent Co-Authors

Tiziano Barbui
Tiziano Barbui FROM-Fondazione per la Ricerca Ospedale di Bergamo
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Alessandro Rambaldi
Alessandro Rambaldi University of Milan
Paola Guglielmelli
Paola Guglielmelli University of Florence
Ayalew Tefferi
Ayalew Tefferi Mayo Clinic
Francesco Passamonti
Francesco Passamonti University of Milan
Francesco Rodeghiero
Francesco Rodeghiero Yamagata University
Giovanni Barosi
Giovanni Barosi University of Pavia
Anna Falanga
Anna Falanga University of Milano-Bicocca
Mario Cazzola
Mario Cazzola University of Pavia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine offers various academic directions, especially for those drawn to the flexibility and accessibility of online learning. Online programs now cater to prospective nurses, experienced RNs, and those holding non-nursing degrees who wish to transition into healthcare.

For registered nurses seeking advancement, there are numerous cheapest rn to bsn online options. These programs are both affordable and designed for working professionals. Similarly, cheap rn to bsn programs can be an accessible pathway to enhance qualifications without incurring significant debt.

Those interested in academic leadership or research may consider phd nursing programs online. These advanced degrees can be earned remotely, providing flexibility for busy healthcare professionals.

Not everyone entering the field begins with a nursing background. If you hold a non-nursing bachelor’s degree, non nursing bachelor's to msn online programs can accelerate your journey to becoming a nurse. These innovative programs allow for a direct entry into advanced nursing roles.

Best Scientists Citing Guido Finazzi

Trending Scientists

Recently Published Articles